On 16 May, IPK scientists and the Business Development team met with Sectoral Asset Management (SAM), an industry-leading specialist in managing global investment portfolios in the healthcare sector, as well as, domestic and international investors.
During the meeting, IPK scientists promoted IPK’s research focuses, achievements, drug discovery pipeline and discussed potential partnership and investment opportunities.